A61P 21 - Drugs for disorders of the muscular or neuromuscular system

Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/1994
12/22/1994	WO1994028922A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype
12/22/1994	CA2163995A1 Spiro-substituted azacycles as neurokinin antagonists
12/20/1994	US5374656 N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them
12/07/1994	EP0626954A1 Benzocycloheptenes, benzoxepines and benzothiepines
11/1994
11/24/1994	WO1994026746A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE
11/24/1994	WO1994026693A1 Bicyclic amide derivatives and their use as muscle relaxants
11/24/1994	WO1994026692A1 Bicyclic amide derivatives and their use as muscle relaxants
11/24/1994	WO1994026308A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins
11/24/1994	WO1994026298A1 Methods for treating muscle diseases and disorders
11/24/1994	CA2162023A1 [1,2,4]triazolo[4,3-a]quinoxaline compounds, their preparation and use
11/23/1994	EP0625153A1 Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
11/23/1994	EP0625048A1 Synthesis of human procollagens and collagens in recombinant dna systems
11/23/1994	EP0543892B1 N-(mercaptoalkyl)ureas and carbamates
11/15/1994	US5364864 Enzyme inhibitors
11/09/1994	EP0623627A1 Sulfonamide derivatives
11/08/1994	US5362738 Used to treat muscle tension, stress, insomnia, anxiety or convulsions
11/01/1994	US5360808 Arylcarbonylaminoalkyl-dihydro-oxo-pyridines, their production and their use
10/1994
10/18/1994	US5356925 For cardiovascular and urogenital disorders
09/1994
09/28/1994	EP0617125A2 A novel transport protein gene from the Huntington's disease region
09/24/1994	CA2118675A1 Transport protein gene from the huntington's disease region
09/20/1994	US5349056 Modified ciliary neurotrophic factors
09/14/1994	EP0614977A2 Huntingtin DNA, protein and uses thereof
09/14/1994	EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
09/14/1994	EP0518960B1 Derivatives of n-phenyl glycinamide, their preparation and medicaments containing them
09/07/1994	EP0613373A1 Risedronate delayed-release compositions
09/06/1994	CA2116280A1 Huntingtin dna, protein and uses thereof
08/1994
08/23/1994	CA1331616C Organic salts of physostigmine derivative
08/09/1994	US5336675 Administering acetylcholinesterase inhibitor which can pass through blood-brain barrier in humans
08/09/1994	CA1331341C Covered retard forms
08/04/1994	WO1994013658A3 Benzocycloheptenes, benzoxepines and benzothiepines
08/03/1994	EP0608353A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES.
07/1994
07/20/1994	EP0606366A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
07/20/1994	EP0606248A1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
07/13/1994	EP0605501A1 Method and compositions for the treatment of cerebral palsy
07/13/1994	EP0605474A1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
07/07/1994	WO1994014814A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor
07/07/1994	CA2151251A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor
06/1994
06/23/1994	WO1994013658A2 Benzocycloheptenes, benzoxepines and benzothiepines
06/23/1994	CA2129642A1 Benzocycloheptenes, benzoxepines and benzothiepines
06/15/1994	EP0642516A4 Macrocyclic immunomodulators.
06/09/1994	EP0638082A4 Macrocyclic immunomodulators.
06/08/1994	EP0600582A1 Treatment for muscular dystrophy
06/07/1994	CA1330087C 1,4-disubstituted-piperidinyl compounds
05/1994
05/26/1994	WO1994009134A3 Modified ciliary neurotrophic factors
05/25/1994	EP0598171A1 Nitrogen bridge tetrahydroisoquinolines
05/17/1994	CA2088436A1 Nitrogen bridge tetrahydroisoquinolines
05/11/1994	EP0595980A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
05/10/1994	US5310756 Aryloxyphenylpropylamines and their calcium overload blocking compositions and methods of use
04/1994
04/28/1994	WO1994009134A2 Modified ciliary neurotrophic factors
04/28/1994	WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
04/28/1994	CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof
04/26/1994	US5306720 Treatment of cerebrovascular disorders
04/20/1994	EP0593176A2 Pharmaceutical compositions containing botulinum toxin and method of preparation
04/12/1994	US5302593 Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors
03/1994
03/31/1994	WO1994006825A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same
03/31/1994	CA2144039A1 Ureido-acetamides derivatives, preparation thereof and drugs containing same
03/30/1994	EP0589488A1 (-)-Cimaterol and its use as a medicament or growth promoter
03/22/1994	US5296492 Certain chroman derivatives useful for treating symptoms caused by contraction of smooth muscles, circulatory diseases or epilepsy
03/08/1994	US5292753 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
03/03/1994	WO1994004532A1 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
03/02/1994	EP0584285A1 Improvements in benzodiazepine treatment by cholinesterase inhibitors
02/1994
02/09/1994	CN1081669A Compounds for the treatment of nemodegenerative disorders
02/03/1994	WO1994002488A1 BIS-STAUROSPORINE AND K-252a DERIVATIVES
02/03/1994	CA2140924A1 Bis-staurosporine and k-252a derivatives
01/1994
01/25/1994	US5281623 Method for treating inflammation
01/19/1994	EP0578687A1 Use of deprenyl to maintain, prevent loss, or recover nerve cell function
01/12/1994	CN1023480C 3-aryl-5-alkylthio-4h-1,2,4-triazoles derivatives and prepn. method therefor
12/1993
12/29/1993	EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them
12/29/1993	EP0575954A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process
12/29/1993	EP0516729B1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them
12/26/1993	CA2099648A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase activity inhibitors and relative preparation process
12/23/1993	WO1993025667A1 D-enzyme compositions and methods of their use
12/23/1993	WO1993025527A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
12/15/1993	EP0573568A1 Use of nicotinic analogs for treatment of degenerative diseases of the nervous system
12/01/1993	EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
11/1993
11/30/1993	US5266570 Piperidine derivatives, compositions and use
11/24/1993	EP0571012A2 Monoqaternary 2, 16-bispiperidinylandrostane derivatives
11/18/1993	EP0569409A1 Amide derivatives and their therapeutic use
11/09/1993	US5260422 MHC conjugates useful in ameliorating autoimmunity
11/09/1993	US5260224 Tissue injury prevention
10/1993
10/28/1993	WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
10/28/1993	CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them
10/27/1993	EP0566647A1 Improved humanized immunoglobulins
10/26/1993	US5256824 Substituted-amine compound and a process for the preparation thereof
10/20/1993	EP0565683A1 Quinoxaline derivates with affinity for quisqualate-receptors
10/14/1993	WO1993020052A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
10/14/1993	WO1993019769A1 Wound healing and treatment of fibrotic disorders
09/1993
09/28/1993	US5248695 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in animal feeds
09/16/1993	WO1993017683A1 Application of 2-amino 6-trifluoromethoxy benzothiazole (riluzole) for obtaining a drug useful in the treatment of motor neuron diseases
09/08/1993	EP0558861A1 Use of amino-2-trifluoromethoxy-6-benzothiazole (riluzole) for the manufacture of a medicament for the treatment of motor neuron diseases
09/07/1993	CA1321994C Acylated uridine and cytidine and uses thereof
09/01/1993	EP0557876A1 Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation
08/1993
08/31/1993	US5240939 Nitrogen bridge tetrahydroisoquinolines
08/25/1993	EP0556738A1 Pyridinylcarbonylaminoalkyl-dihydro-oxo-pyridines, their production and their use
08/25/1993	CN1075480A Novel arvlcarbonylaminoalkyl-dihydro-oxo-pyridines, their production and their use
08/23/1993	CA2089959A1 Use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation
08/21/1993	CA2089955A1 Arylcarbonylaminoalkyl-dihydro-oxo-pyridines, their production and their use
08/19/1993	WO1993016074A1 Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same
08/18/1993	EP0339075B1 Acylated uridine and cytidine and uses thereof
08/11/1993	EP0554543A2 1,2,4-Triaminobenzene derivatives and process for their preparation

1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233